Goodrx Holdings Inc
NASDAQ:GDRX

Watchlist Manager
Goodrx Holdings Inc Logo
Goodrx Holdings Inc
NASDAQ:GDRX
Watchlist
Price: 4.44 USD -1.11% Market Closed
Market Cap: 1.7B USD
Have any thoughts about
Goodrx Holdings Inc?
Write Note

Goodrx Holdings Inc
Net Issuance of Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Goodrx Holdings Inc
Net Issuance of Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Goodrx Holdings Inc
NASDAQ:GDRX
Net Issuance of Common Stock
-$98m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Veeva Systems Inc
NYSE:VEEV
Net Issuance of Common Stock
$75.6m
CAGR 3-Years
13%
CAGR 5-Years
39%
CAGR 10-Years
22%
Inspire Medical Systems Inc
NYSE:INSP
Net Issuance of Common Stock
$30.6m
CAGR 3-Years
26%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Net Issuance of Common Stock
-$264.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Omnicell Inc
NASDAQ:OMCL
Net Issuance of Common Stock
$13.4m
CAGR 3-Years
-44%
CAGR 5-Years
-35%
CAGR 10-Years
N/A
W
Waystar Holding Corp
NASDAQ:WAY
Net Issuance of Common Stock
-$263k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Goodrx Holdings Inc
Glance View

Market Cap
1.7B USD
Industry
Health Care

GoodRx Holdings Inc., established at the intersection of healthcare and technology, has carved a niche in the American pharmaceutical industry by addressing one of its most notorious challenges: the high cost of prescription medications. Originally founded in 2011, GoodRx aims to ease the financial burden of medication costs for consumers by providing a platform that aggregates drug pricing information from pharmacies across the United States. By doing so, it empowers users to compare prices, identify potential savings, and subsequently make informed decisions about their medication purchases. At its core, GoodRx operates as a digital intermediary; its app and website seamlessly connect consumers with discounted prescription offers through partnerships with pharmacy benefit managers (PBMs) and retail pharmacies. The company's revenue model is primarily built on a commission and advertising framework. When users select a coupon from GoodRx and purchase at a pharmacy, the company receives a fee from its pharmacy partners or PBMs. Additionally, GoodRx leverages its vast user base, which is largely driven by organic traffic resulting from the essential nature of its service, to generate advertising revenues from pharmaceutical companies and other health-related entities eager to reach consumers actively seeking medication solutions. By continually expanding its services, such as telehealth offerings and a subscription model called GoodRx Gold, the company seeks to deepen its integration into the consumer healthcare experience while maintaining its core mission of providing accessible and affordable medication options.

GDRX Intrinsic Value
10.95 USD
Undervaluation 59%
Intrinsic Value
Price

See Also

What is Goodrx Holdings Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
-98m USD

Based on the financial report for Dec 31, 2023, Goodrx Holdings Inc's Net Issuance of Common Stock amounts to -98m USD.

What is Goodrx Holdings Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 1Y
-6%

Over the last year, the Net Issuance of Common Stock growth was -6%.

Back to Top